Sjællands Universitetshospital, Roskilde; Øjenafdelingen
About Sjællands Universitetshospital, Roskilde; Øjenafdelingen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Clinical Trials at Sjællands Universitetshospital, Roskilde; Øjenafdelingen
During the past decade, Sjællands Universitetshospital, Roskilde; Øjenafdelingen conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
2023-12-29
2026-01-30
Suspended
560
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sjællands Universitetshospital, Roskilde; Øjenafdelingen
According to Clinical.Site data, the most researched conditions in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are
"Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Neovascular Age-Related Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" in a lesser frequency.
Clinical Trials Intervention Types at Sjællands Universitetshospital, Roskilde; Øjenafdelingen
Most popular intervention types in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are "Drug" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Lampalizumab" (2 trials) and "Port Delivery System with ranibizumab (PDS)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sjællands Universitetshospital, Roskilde; Øjenafdelingen
The vast majority of trials in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are
7 trials for "All" genders.
Clinical Trials Status at Sjællands Universitetshospital, Roskilde; Øjenafdelingen
Currently, there are NaN active trials in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Sjællands Universitetshospital, Roskilde; Øjenafdelingen,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sjællands Universitetshospital, Roskilde; Øjenafdelingen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".